These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25204434)

  • 41. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
    Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
    Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S18986: a positive modulator of AMPA-receptors enhances (S)-AMPA-mediated BDNF mRNA and protein expression in rat primary cortical neuronal cultures.
    Lockhart BP; Rodriguez M; Mourlevat S; Peron P; Catesson S; Villain N; Galizzi JP; Boutin JA; Lestage P
    Eur J Pharmacol; 2007 Apr; 561(1-3):23-31. PubMed ID: 17331496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.
    Pøhlsgaard J; Frydenvang K; Madsen U; Kastrup JS
    Neuropharmacology; 2011 Jan; 60(1):135-50. PubMed ID: 20713069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardiovascular action of 1,2,4-benzothiadiazine-1,1-dioxide derivatives. IX].
    Parenti C; Di Bella M; Raffa L; Baggio GG; Guarini S
    Farmaco Sci; 1983 Oct; 38(10):738-49. PubMed ID: 6641925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thermodynamics and structural analysis of positive allosteric modulation of the ionotropic glutamate receptor GluA2.
    Krintel C; Frydenvang K; Olsen L; Kristensen MT; de Barrios O; Naur P; Francotte P; Pirotte B; Gajhede M; Kastrup JS
    Biochem J; 2012 Jan; 441(1):173-8. PubMed ID: 21895609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chlorophenylmethyl benzothiadiazine dioxides derivatives: potent human cytomegalovirus inhibitors.
    Martinez A; Gil C; Perez C; Castro A; Prieto C; Otero J
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3133-6. PubMed ID: 10560739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: Synthesis and structure-activity relationships.
    Varano F; Catarzi D; Colotta V; Lenzi O; Filacchioni G; Galli A; Costagli C
    Bioorg Med Chem; 2008 Mar; 16(5):2617-26. PubMed ID: 18063372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemo-enzymatic synthesis of a series of 2,4-syn-functionalized (S)-glutamate analogues: new insight into the structure-activity relation of ionotropic glutamate receptor subtypes 5, 6, and 7.
    Sagot E; Pickering DS; Pu X; Umberti M; Stensbøl TB; Nielsen B; Chapelet M; Bolte J; Gefflaut T; Bunch L
    J Med Chem; 2008 Jul; 51(14):4093-103. PubMed ID: 18578478
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation, and molecular modeling study.
    Varano F; Catarzi D; Colotta V; Calabri FR; Lenzi O; Filacchioni G; Galli A; Costagli C; Deflorian F; Moro S
    Bioorg Med Chem; 2005 Oct; 13(19):5536-49. PubMed ID: 16087341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists. Synthesis, pharmacological, and molecular modeling studies.
    Colotta V; Catarzi D; Varano F; Lenzi O; Filacchioni G; Costagli C; Galli A; Ghelardini C; Galeotti N; Gratteri P; Sgrignani J; Deflorian F; Moro S
    J Med Chem; 2006 Oct; 49(20):6015-26. PubMed ID: 17004715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benzothiadiazines derivatives as novel allosteric modulators of kainic acid receptors.
    Puja G; Ravazzini F; Losi G; Bardoni R; Battisti UM; Citti C; Cannazza G
    J Physiol Pharmacol; 2022 Feb; 73(1):. PubMed ID: 35639034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacology of ionotropic glutamate receptors: A structural perspective.
    Stawski P; Janovjak H; Trauner D
    Bioorg Med Chem; 2010 Nov; 18(22):7759-72. PubMed ID: 20947363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 4-Alkylated homoibotenic acid (HIBO) analogues: versatile pharmacological agents with diverse selectivity profiles towards metabotropic and ionotropic glutamate receptor subtypes.
    Madsen U; Pickering DS; Nielsen B; Bräuner-Osborne H
    Neuropharmacology; 2005; 49 Suppl 1():114-9. PubMed ID: 15996690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and blood pressure lowering activity of 3-(substituted-amino)-1,2,4-benzothiadiazine 1-oxide derivatives.
    Dillard RD; Yen TT; Stark P; Pavey DE
    J Med Chem; 1980 Jul; 23(7):717-22. PubMed ID: 7401100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 7-Phenoxy-Substituted 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-Dioxides as Positive Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors with Nanomolar Potency.
    Goffin E; Drapier T; Larsen AP; Geubelle P; Ptak CP; Laulumaa S; Rovinskaja K; Gilissen J; Tullio P; Olsen L; Frydenvang K; Pirotte B; Hanson J; Oswald RE; Kastrup JS; Francotte P
    J Med Chem; 2018 Jan; 61(1):251-264. PubMed ID: 29256599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. (S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
    Brehm L; Greenwood JR; Hansen KB; Nielsen B; Egebjerg J; Stensbøl TB; Bräuner-Osborne H; Sløk FA; Kronborg TT; Krogsgaard-Larsen P
    J Med Chem; 2003 Apr; 46(8):1350-8. PubMed ID: 12672235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aryl- and heteroaryl-substituted phenylalanines as AMPA receptor ligands.
    Szymańska E; Chałupnik P; Johansen TN; Nielsen B; Cuñado Moral AM; Pickering DS; Więckowska A; Kieć-Kononowicz K
    Chem Biol Drug Des; 2017 Dec; 90(6):1271-1281. PubMed ID: 28636281
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular structure of ionotropic glutamate receptors.
    Kaczor AA; Matosiuk D
    Curr Med Chem; 2010; 17(24):2608-35. PubMed ID: 20491632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of novel modulators for ionotropic glutamate receptor, iGluA2 by in-silico screening.
    Padmanabhan B
    Theor Biol Med Model; 2013 Jul; 10():46. PubMed ID: 23855825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis, and biological evaluation of a scaffold for iGluR ligands based on the structure of (-)-dysiherbaine.
    Cohen JL; Limon A; Miledi R; Chamberlin AR
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2189-94. PubMed ID: 16455241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.